Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation
Accessnewswire·2025-11-20 14:00
Conformity with stringent new EU regulations for medical devices confirmed Allows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countries Major milestone in international growth strategy HAMILTON, BERMUDA / ACCESS Newswire / November 20, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and supplying nucleic acid delivery technology for partners in biotech and pharma, today announced that ...